↓
 

Monthly Archives: May 2019

Dr. Ross Camidge (Pt 1): Working at the Forefront of Developing New Targets and New Therapies

Dr. Ross Camidge from the University of Colorado discusses his career trajectory, how cancer research in narrow molecularly defined populations has evolved, challenges in molecular oncology practice, & the brain as a new frontier for treatment efficacy. (24:40)

Dr. Mark Lewis (Pt. 3): Raising a Family while Managing a Familial Cancer Syndrome

Dr. Mark Lewis and host Jack West reflect on the personal decisions involved with having children with the uncertainty of a familial cancer syndrome, as well as the power of connectivity through medical discussions on social media. (24:05)

Dr. Mark Lewis (Pt. 2): Managing My Cancer Diagnosis, from Watchful Waiting to a Whipple Procedure

Dr Jack West & guest Mark Lewis discuss the evolution of his cancer as his care evolves from watchful waiting to a decision to pursue a Whipple procedure, the challenges of recovery, & his approach to discussing his own experiences with his patients. (19:28)

Dr. Mark Lewis (Pt. 1): The Fateful Path to a Medical Career and Self-Diagnosis

Dr. Mark Lewis and host Jack West trace back from his father’s surprise diagnosis of cancer to his own path into medicine, ultimately his self-diagnosis with a familial genetic syndrome. (23:15)

Dr. Greg Riely (Pt 2): Should local ablation therapy in oligometastatic or oligoprogressing cancer be incorporated into routine practice?

Dr. Greg Riely from MSKCC and Dr. Jack West review the changing role for plasma NGS and local ablation therapy (LAT) for oligometastic disease (OMD) or oligoprogressing advanced NSCLC in clinical practice. (28:11)

Dr. Greg Riely (Pt 1): Current Practice & Challenges in Execution of Genomic Testing in Lung Cancer Treatment

Dr. Greg Riely from Memorial Sloan-Kettering Cancer Center (MSKCC) chats with Dr. Jack West about current standards in molecular testing for advanced NSCLC & potential challenges in execution in translating the promise of genomics into broad practice. (19:57)

Dr. Sanjay Mukhopadhyay (Pt. 2): Integrating Artificial Intelligence, Telemedicine, and Other New Technologies to Improve Pathology Globally

Dr. Jack West & pulmonary pathologist Sanjay Mukhopadhyay, MD from the Cleveland Clinic discuss changing workflows in pathology introduced by artificial intelligence, telemedicine, & new digital platforms for education & support. (27:17)

Dr. Sanjay Mukhopadhyay (Pt. 1): Medical Education & Outreach in the Age of Social Media

Dr. Sanjay Mukhopadhyay, pathologist at Cleveland Clinic, speaks with Dr. Jack West about the strong pathology community on Twitter and how social media are providing new opportunities to share information and create broader medical communities. (26:13)

Dr. Bishal Gyawali (Part 2): The Cancer Ground-Shot, Enforcing Common Sense, and Stirring the Pot While Rethinking Dubious Standards in Cancer Care

Dr. Bishal Gyawali and Dr. Jack West discuss the concept of a “cancer ground-shot,” challenges to enforce common sense in oncology, and questions about low standards for FDA approvals that may not truly improve outcomes for patients with cancer. (20:40)

↑